Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Diatrizoate and Iodipamide
Latest prescription information about Diatrizoate and Iodipamide. Learn how to pronounce the drug’s name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, its storage instructions and warnings if any when taken during pregnancy. Also listed are the International and Indian trade name(s) of the drug and its price list.
|
Generic Name : Diatrizoate and Iodipamide
Therapeutic Classification : Diagnostic Agents
ICD Code : Y57.6
Trade Name(s): International- Sinografin. Why it is prescribed (Indications) : This medication is radiopaque contrast medium, prescribed for use in hysterosalpingography (X-ray of the uterus and fallopian tubes ). When it is not to be taken (Contraindications): Contraindicated in pregnant women. It should not be attempted during menstrual period, within 30 days following curettage or within six months following the termination of pregnancy.
Dosage & When it is to be taken : The recommended dose range is 1.5 to 10 mL. How it should be taken : It comes as a solution, administered via uterine cannula. Warnings and Precautions : * Caution should be exercised in patients with history of allergy to iodine, any foods, or X-ray dyes, uterine cancer, asthma, any allergy, and during breastfeeding. Side Effects : Common- Hypersensitivity reactions, which include sweating, flushing, itching, hives, skin rashes, joint pain, respiratory distress, dizziness, syncope, low blood pressure, chills, fever, nausea, vomiting, and abdominal pain and tenderness. Rare - Slow heart rate, low blood pressure, heart arrest and death. * Avoid excess dosage. Storage Conditions : Store at 20-25°C. Protect from light. |
 Comment & Contribute
| ||
Browse the Drugs alphabetically
Reference
- Food and Drug Administration (FDA)
- National Institutes of Health (NIH)
- PubMed
- CIMS
- Indian Pharma Reference Guide 2012
Ask an Expert
